 BGI Genomics. Co. Ltd. SZSE:300676 today announced that it has received approval from the U.S. Food and Drug Administration FDA for expanding its offering of SARS-CoV-2 RT-PCR Test under emergency use authorization to include the RNA extraction kit and automated liquid handling system made by MGI 